The Fasting Blood Sugar (FBS) test measures the amount of glucose circulating in the blood plasma after a period of fasting. It serves as a primary diagnostic tool for evaluating carbohydrate metabolism disorders, most notably diabetes mellitus. Unlike random blood glucose testing, the fasting protocol eliminates recent dietary intake as a variable, offering a baseline measurement of how the body maintains blood glucose homeostasis during periods without food.
Glucose homeostasis relies on a precise hormonal feedback loop involving the pancreas and the liver.
Clinicians order the FBS test for multiple diagnostic and monitoring purposes. Routine screening is recommended for adults over age 45 or individuals with risk factors like obesity, hypertension, or a family history of diabetes. It is also used to monitor therapeutic effectiveness in diagnosed diabetic patients and to investigate unexplained symptoms such as polyuria, polydipsia, and unexplained weight loss.
Accurate test results depend heavily on strict adherence to pre-test instructions. The patient must fast for a minimum of eight hours, typically overnight, consuming only water. Ingesting food, coffee, tea, or juice stimulates metabolic activity and alters glucose levels. Nurses must also review the patient's medication chart, as certain drugs like corticosteroids or thiazide diuretics can artificially elevate blood sugar.
Collecting a fasting blood sample requires standard venipuncture techniques following verification of the patient's identity and fasting status.
Laboratory reference ranges guide the clinical interpretation of fasting blood sugar levels. A normal fasting plasma glucose generally falls below 100 mg/dL (5.6 mmol/L). Values between 100 mg/dL and 125 mg/dL indicate impaired fasting glucose, commonly referred to as pre-diabetes. A reading of 126 mg/dL (7.0 mmol/L) or higher, confirmed on a separate occasion, establishes a provisional diagnosis of diabetes mellitus.
Abnormal fasting glucose levels point toward underlying metabolic disruptions. Hyperglycemia indicates insufficient insulin action or excessive counter-regulatory hormones, requiring further assessment with an HbA1c test or oral glucose tolerance test. Conversely, hypoglycemia during a fasting state can point toward insulinomas, severe hepatic disease, or medication overdosage, demanding prompt clinical investigation.
Several physiological and external variables can skew fasting blood sugar results, leading to misdiagnosis. Acute stress from surgery, trauma, or severe infection triggers cortisol and epinephrine release, raising blood glucose. Conversely, intense physical exertion immediately prior to the test can cause unpredictable fluctuations. Medication interactions, such as beta-blockers masking hypoglycemia or corticosteroids raising glucose, must also be considered.
Once the blood sample is collected, patient management shifts to recovery and education. The nurse should immediately offer the patient their postponed meal and scheduled medications, especially insulin or oral hypoglycemics that were held during the fast. Education should focus on explaining the test results, discussing lifestyle modifications such as diet and exercise, and instructing the patient on recognizing symptoms of hypoglycemia.